Alzheimer’s disease (AD) is a progressive brain disorder that affects neurological functioning specifically targeting cognition, memory and behaviour. Pathology starts with the accumulation of tau proteins which on phosphorylation can be destructive for brain function. With gold standard drugs like Donepezil, there have been several attempts made to discover adjuvant therapeutic molecules such as plant-based products that could not only ease the ill-toward effects of these drugs, but also lead to the betterment of the patients suffering from AD. These are crucial in the management of patients of AD, by associations with psychological vulnerabilities and the overall loss of health of such individuals ‘Resveratrol’ is one such plant-based molecule which is a stilbene polyphenol present in many of the commonly occurring plants. Resveratrol is reported to have anti-oxidant and anti-inflammatory properties which brings about the neuroprotection. Several studies have also been conducted that targets the signalling cascades involved during the progression of AD. This review attempts to give a collective information of its properties, its synthesis, metabolism and mechanisms that could drive researchers forward for its therapeutic applications during the treatment of Alzheimer’s disease.

Adult vaccination is a critical component of preventive healthcare, reducing morbidity and mortality from vaccine-preventable diseases. Despite established recommendations, adult immunisation coverage remains suboptimal, particularly for vaccines beyond influenza and COVID-19. In the United Arab Emirates (UAE), limited evidence exists regarding adult vaccine uptake and determinants influencing immunisation behaviour within its diverse population. Understanding vaccine-specific coverage and associated sociodemographic, healthcare, and workplace factors is essential to guide targeted strategies that strengthen adult immunisation. A cross-sectional study was conducted among 1330 adults aged ≥ 18 years residing in the UAE. Data were collected using a structured self- or interviewer-administered questionnaire assessing uptake of recommended adult vaccines, including COVID-19, influenza, pneumococcal, herpes zoster, Tdap, and HPV. Sociodemographic characteristics, healthcare access, insurance status, workplace factors, and perceived barriers were also assessed. Descriptive statistics summarised vaccination coverage, and associations between uptake and key determinants were examined using SPSS version 30. Statistical significance was defined as p < 0.05. Overall, 71.0% reported receiving at least one adult vaccine. Uptake was highest for COVID-19 (64.9%) and influenza (57.8%), while pneumococcal, herpes zoster, and Tdap coverage remained low (12–13%). HPV uptake was 22.6% among females and 18.9% among males. Higher uptake was observed among females and adults. Social encouragement, insurance coverage, and healthcare access were associated with vaccination, whereas lack of awareness and logistical barriers hindered uptake. Although overall uptake was moderate, significant gaps persist. Integrating vaccination into routine healthcare services and addressing structural and communication barriers are necessary to improve adult vaccination coverage.

Urinary incontinence (UI) is a common problem in women and can have negative effects on physical, psychological, social and sexual health. There is limited evidence on its distribution and associated factors in the United Arab Emirates (UAE). The objective of this study was to determine the distribution of UI subtypes and to study the association of UI with selected sociodemographic, obstetric and gynaecological factors among women attending a tertiary care center in the UAE. A retrospective observational study was conducted in a tertiary hospital in Ajman, UAE, utilising the medical records of women with documented or reported UI from January 2021 to January 2026. Sociodemographic, anthropometric, obstetric, and gynaecological data were extracted by a structured proforma and reviewed by a specialist. Associations between categorical variables and UI subtype were evaluated using Chi-square or Fisher’s exact tests. Statistical significance was set at p ≤ 0.05. Among the 210 women included, the most common subtype was SUI (40.5%), followed by UUI (32.4%) and MUI (27.1%). Age was significantly associated with UI subtype (p = 0.012). SUI was more common in women aged 30–49 years and MUI in those aged ≥50 years. Subtype was also significantly associated with menopausal status (p = 0.012) and pelvic organ prolapse (p = 0.002). Nationality, BMI, parity, mode of delivery and pelvic surgery were not significantly associated. Early identification and focused evaluation may allow for timely intervention. More generalisable estimates of UAE will require prospective multicentre studies.